TipRanks
ProMIS Neurosciences (DE:23J)
FRANKFURT:23J
Germany Market
23J
ProMIS Neurosciences
RESEARCH TOOLSreports

ProMIS Neurosciences (23J) Stock News & Sentiment

3 Followers
Analyst Reiterates Buy on ProMIS Neurosciences, Maintaining $35 Price Target Amid Strong Cash Position and PMN310 Clinical Progress
Premium
Ratings
Analyst Reiterates Buy on ProMIS Neurosciences, Maintaining $35 Price Target Amid Strong Cash Position and PMN310 Clinical Progress
2M ago
PMN
PMN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PMN Earnings this Week: How Will it Perform?
2M ago
PMN
PMN310’s Clean Safety and Promising Biomarkers Drive Buy Rating; $35 Price Target Reiterated
Premium
Ratings
PMN310’s Clean Safety and Promising Biomarkers Drive Buy Rating; $35 Price Target Reiterated
2M ago
PMN
ProMIS Reports Positive Interim PMN310 Alzheimer’s Trial Data
Premium
Company Announcements
ProMIS Reports Positive Interim PMN310 Alzheimer’s Trial Data
2M ago
8K
PMN
Buy Rating Reiterated on PMN310’s Promising Phase 1a Data and Unchanged $18 Price Target
Premium
Ratings
Buy Rating Reiterated on PMN310’s Promising Phase 1a Data and Unchanged $18 Price Target
3M ago
PMN
Analyst Reiterates Buy on ProMIS Neurosciences, Maintains $18 Price Target on Differentiated Alzheimer’s Candidate PMN310
Premium
Ratings
Analyst Reiterates Buy on ProMIS Neurosciences, Maintains $18 Price Target on Differentiated Alzheimer’s Candidate PMN310
4M ago
PMN
Ram Selvaraju Reiterates Buy on ProMIS Neurosciences, Maintains $18 12-Month Price Target on Differentiated PMN310 Alzheimer’s Profile
Premium
Ratings
Ram Selvaraju Reiterates Buy on ProMIS Neurosciences, Maintains $18 12-Month Price Target on Differentiated PMN310 Alzheimer’s Profile
4M ago
PMN
More DE:23J News >

23J News on the Web

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS) and ProMIS Neurosciences (PMN)
TipRanks News
Bullish
Analyst Reiterates Buy on ProMIS Neurosciences, Maintaining $35 Price Target Amid Strong Cash Position and PMN310 Clinical Progress
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: ProMIS Neurosciences (PMN), Ascendis Pharma (ASND)
TipRanks News
Bullish
Q2 2026 ProMIS Neurosciences Inc Earnings Call Transcript
GuruFocus News
Neutral
PMN Earnings this Week: How Will it Perform?
TipRanks News
Bullish
Senior Executive Makes Bold Insider Move on ProMIS Neurosciences Stock
TipRanks News
Neutral
Top Biotech Gainers: KNSA Soars On Q2 Results, TRIB, OPK On Watch, MPLT On The Mend?
rttnews
Bullish
ProMIS Neurosciences’ PMN310 shows positive result in Alzheimer’s Phase 1b trial
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:23J
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is DE:23J’s Media Buzz Sentiment?
Currently, no data Available
What is DE:23J’s weekly average amount of articles?
Currently, no data Available
What is DE:23J’s News Sentiment?
50% of articles about DE:23J were positive this week, compared to its sector average of 91%.
    Healthcare Stocks that are Trending in the News
    AMGNAmgen
    GKOSGlaukos
    OVIDOvid Therapeutics
    ABTAbbott Laboratories
    IQVIQVIA Holdings
    Showing the stocks with the most bullish news sentiment over the past week